Welcome Guest
Sign In
Register
Research & Development
Quality
Regulatory
Manufacturing
Home
News
Articles
MAGAZINE
Resources
Sponsored Q&A
Whitepapers
eBooks
Infographics
Videos
Webinars
Products
Featured Products
New Products
Events
FAQ
George Buchman, Ph.D.
George Buchman, Ph.D.
Research Fellow
Catalent Cell & Gene Therapy
Articles by George Buchman, Ph.D.
What sponsors should know about FDA’s platform technology designation
Tuesday, January 20, 2026
Sponsors with a licensed gene therapy can use the same vector platform to reference manufacturing, analytical and safety data for other candidates.
Subscribe to eNewsletters
Keep up with latest in cell and gene therapy news and events, delivered straight to your inbox.
Subscribe to Magazine
Jan/Feb/Mar 2026 edition now available!
Get started here for your complimentary print or digital subscription
Sign up Now »
Upcoming Events
INTERPHEX 2026
April 21-23, 2026
Meeting on the Med 2026
April 28-30, 2026
TRI-CON 2026: Entering the Age of AI
May 4-5, 2026
Connect with Us